Company intelligence / Profile preview

Nicoya Macau

Macau, Macau

Ownership: Private
Development stage: Other

Overview

Nicoya Macau is a regional entity of Nicoya Lifesciences, a Canadian biotechnology company specializing in advanced analytical instruments for the life sciences industry. The company is best known for its Surface Plasmon Resonance (SPR) platforms, including OpenSPR and Alto, which enable researchers to perform high-sensitivity, label-free biomolecular interaction analysis. Nicoya's technology is utilized in drug discovery, protein characterization, and academic research to measure binding kinetics and affinity. The Macau office serves as a strategic hub for business development, technical support, and distribution within the Greater China and Asia-Pacific markets.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Nicoya Macau.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicoya Macau.

Explore the full profile